CA
SRNE

Cliff Asness’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Cliff Asness’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-16,892
Closed -$79K – 2325
2021
Q4 		$79K Sell
16,892
-12,038
-42% -$74.7K ﹤0.01% 2163
2021
Q3 		$221K Sell
28,930
-44,011
-60% -$373K ﹤0.01% 2127
2021
Q2 		$707K Sell
72,941
-65,343
-47% -$520K ﹤0.01% 1734
2021
Q1 		$1.14M Buy
138,284
+17,373
+14% +$183K ﹤0.01% 1493
2020
Q4 		$825K Sell
120,911
-9,208
-7% -$74K ﹤0.01% 1587
2020
Q3 		$1.45M Buy
130,119
+92,530
+246% +$847K ﹤0.01% 1247
2020
Q2 		$236K Buy
37,589
+8,897
+31% +$34.1K ﹤0.01% 1955
2020
Q1 		$53K Buy
+28,692
New +$82.6K ﹤0.01% 2005
2019
Q2 		– Sell
-10,873
Closed -$52K – 2222
2019
Q1 		$52K Sell
10,873
-147,623
-93% -$387K ﹤0.01% 2151
2018
Q4 		$380K Sell
158,496
-106,162
-40% -$347K ﹤0.01% 1878
2018
Q3 		$1.16M Buy
264,658
+101,538
+62% +$563K ﹤0.01% 1648
2018
Q2 		$1.17M Buy
+163,120
New +$1.11M ﹤0.01% 1646
2016
Q1 		– Sell
-124,448
Closed -$1.08M – 2306
2015
Q4 		$1.08M Buy
124,448
+2,617
+2% +$22.1K ﹤0.01% 1530
2015
Q3 		$1.02M Buy
+121,831
New +$1.94M ﹤0.01% 1413
2015
Q1 		– Sell
-10,700
Closed -$108K – 2357
2014
Q4 		$108K Sell
10,700
-5,100
-32% -$25.8K ﹤0.01% 2433
2014
Q3 		$71K Sell
15,800
-800
-5% -$4.3K ﹤0.01% 2472
2014
Q2 		$112K Buy
+16,600
New +$125K ﹤0.01% 2451

Other funds holding SRNE

State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $43.9B AUM 121.74% 1-Year Est. Return

Cliff Asness's SRNE Position: Q1 2022 in Review

Cliff Asness sold out of Sorrento Therapeutics, Inc. (SRNE) in Q1 2022, closing a stake of 16,892 shares — an estimated $79K sold.

Cliff Asness first reported a position in SRNE in Q2 2014 and held it in 17 quarters. The position peaked at $1.45M in Q3 2020. 235 funds tracked by Wall St. Rank hold SRNE as of Q1 2022.

  • Cliff Asness reported no remaining Sorrento Therapeutics, Inc. position as of Q1 2022 after selling out during the quarter.
  • Cliff Asness sold 16,892 Sorrento Therapeutics, Inc. shares in Q1 2022, an estimated $79K.
  • Cliff Asness first reported a position in Sorrento Therapeutics, Inc. in Q2 2014 and held it in 17 quarters.
  • Cliff Asness's Sorrento Therapeutics, Inc. position peaked at $1.45M in Q3 2020.
  • 235 funds tracked by Wall St. Rank held Sorrento Therapeutics, Inc. as of Q1 2022.

Based on AQR Capital Management's 13F filing for Q1 2022, filed 16 May 2022.